Vesalius Biocapital invests in young, innovative European life science companies, with a focus on companies active in human health. They target companies with sound proprietary technology, corresponding IP, unique team skills, and a clear competitive edge based on solid data. They act as lead investors in the majority of their financing rounds, and invest in all stages of development, including relatively early-stage projects. They offer venture capital to help build companies based on a sound business case, optimize business plans, provide introductions to other venture capital players and leading healthcare companies, assist with hiring, and aid in exit optimization. Vesalius Biocapital's investment strategy is focused on three areas: therapeutics, medical devices, and diagnostics. They invest progressively in their portfolio companies and commit up to €10 million in a single portfolio company over several rounds of financing, with the possibility of smaller seed investments. They take an active role in their investments by leading or co-leading investments and holding a board seat. Their companies are based in Europe allowing for easy interaction with management.
Preferred startup development maturity for initial funding deployment.
therapeutics, medical devices, diagnostics
Core thematic spaces, technologies, and target market segments of interest.
Standard financial allocation per investment round.
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...